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ABSTRACT
Cryopreservation is essential for tissue engineering and regenerative medicine. This study was carried out to assess 
the effect of cryopreservation on skin cells and evaluate the performance of cells after 12 months of cryopreservation. 
Redundant skin tissue samples were obtained from surgery with consent from patients. The tissue was cleaned, processed 
and cultured until passage 3. Upon confluency, cells were trypsinised and total cell yield and viability were determined 
before and after being cryopreserved. Sterility and immunocytochemistry analysis for collagen type I (Col-1) and 
cytokeratin 14 (CK14) antibodies were also performed on cells cryopreserved for one, three, six and twelve months. There 
is no significant difference in growth rates for cryopreserved cells for 1 to 12 months, except for fibroblasts at 6 months. 
Cell viability for both keratinocytes and fibroblasts decreased with time (65%± 3.5% - 89%± 4.5%). Sterility testing 
showed no contamination after 12 months of cryopreservation. Immunocytochemistry analysis showed positive expression 
for CK14 (keratinocytes) and Col -1 (fibroblasts) after 12 months of cryopreservation. Morphologically, keratinocytes 
and fibroblasts were able to retain its phenotype. The loss in viability is consistent in all samples and possibly due to 
thermal-cycling effect. Immunocytochemistry and consistent cell growth analysis showed that keratinocytes and fibroblasts 
were able to retain their characteristics in cryopreservation condition. These preliminary findings show that primary 
skin cells can be stored via cryopreservation and still retain their characteristics. However, further investigations using 
longer periods of cryopreservation (24 months, 48 months) should be conducted.
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ABSTRAK
Pengawetan krio adalah penting bagi bidang kejuruteraan tisu dan penjanaan semula perubatan. Kajian ini dijalankan 
untuk menilai kesan pengawetan krio pada sel kulit dan prestasi sel selepas pengawetan krio selama 12 bulan. Sampel 
tisu kulit berlebihan daripada pembedahan diambil dengan kebenaran pesakit. Tisu dibersihkan, diproses dan dikultur 
sehingga subkultur 3. Selepas mencapai kepadatan sesuai, sel dituai dan jumlah keseluruhan sel berserta keviabelan 
sel ditentukan sebelum dan selepas pengawetan krio. Ujian kesterilan dan imunositokimia menggunakan antibodi 
kolagen jenis I (Col-1) dan sitokeratin-14 (CK14) dijalankan terhadap sel bagi bulan pertama, ketiga, keenam dan 
kedua belas. Tidak terdapat perbezaan signifikan bagi kadar pertumbuhan sel yang telah diawet bagi bulan pertama 
dan kedua belas, kecuali bagi sel fibroblas pada bulan keenam. Keviabelan sel bagi keratinosit dan fibroblas menurun 
mengikut peningkatan masa (65%± 3.5% - 89%± 4.5%). Ujian kesterilan menunjukkan tiada sebarang pelumusan 
selepas dua belas bulan pengawetan krio. Secara morfologi, keratinosit dan fibroblas mampu mengekalkan fenotipnya. 
Pengurangan keviabelan adalah konsisten bagi semua sampel dan ini mungkin berlaku akibat daripada kesan kitaran 
terma. Analisis imunositokimia dan pertumbuhan sel yang tekal menunjukkan bahawa keratinosit dan fibroblas berupaya 
untuk mengekalkan cirinya setelah pengawetan krio. Keputusan awal ini menunjukkan sel kulit primer boleh disimpan 
melalui proses pengawetan krio dan cirinya dikekalkan. Namun, kajian lanjutan menggunakan tempoh pengawetan krio 
yang lebih lama (24 bulan, 48 bulan) perlu dijalankan.
Kata kunci: Pengawetan krio; pengekspresan gen; sel kulit manusia; sel pembiakan 
INTRODUCTION
Regenerative medicine, as its name implies, involves 
regeneration of organ or tissue, an approach towards 
treating different degenerative diseases. One of the 
earliest initiatives of regenerative medicine has been 
skin regeneration, due to the simplicity of its structure 
and accessibility. Being the outer layer of the body, skin 
is the largest organ in human, which also functions as 
the first line of defence. Hence, huge skin loss, resulting 
from trauma, burns or diabetic ulceration, can be fatal 
and requires special attention and sometimes extensive 
measures (Kalyanaraman & Boyce 2009). History implies, 
that culturing epidermal keratinocytes has started way back 
in 1970’s, pioneered by Rheinwald and Green (1975). Since 
then, a few different methods were developed to explore 
regeneration of the single and bilayer skin equivalents. 
Manipulation of skin cells, which consists mostly of 
keratinocytes and fibroblasts require several standard 
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steps: Cell isolation from a skin biopsy, cell isolation 
through digestion, cell proliferation in monolayer culture, 
construction of bilayered skin in the form of fibrin-
fibroblast and fibrin-keratinocyte skin equivalent, and 
finally implantation on the damaged area (Mazlyzam et 
al. 2007). 
 At the same time, storage methods of the cells and 
engineered tissues also have received much attention. 
One of the most widely used cell storage method is 
cryopreservation. Cryopreservation is a process where 
living cells or tissues are stored at -196ºC in liquid 
nitrogen. At this temperature, biological activities 
including biochemical reactions causing cell death, are 
effectively halted. In the absence of cryoprotectants, 
preserved cells are likely to be damaged due to freeze-
thawing process. Synth-a-Freeze and dimethylsulfoxide 
(DMSO) + 10% Feotal Bovine Serum (FBS) are frequently 
used as cryoprotectants for keratinocytes and fibroblasts, 
respectively. Synth-a-Freeze is a defined, liquid 
cryopreservation medium that contains 10% (DMSO) 
without any growth factors, hormones, antimycotics, 
antibiotics, serum or proteins while 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) and sodium 
bicarbonate function as buffers. Synth-a-Freeze was 
manufactured for freezing and storing mammalian 
cells which include human keratinocytes and stem cells 
(mesenchymal, neural and embryonic). DMSO has also 
been widely used for cryopreserving different cells 
and tissues. Even though the current cryopreservation 
methods have proven to be clinically effective, its optimal 
level is still in question (Hunt 2011).
 A previous study demonstrated that the skin substitute 
MyDerm™ can be kept in pure F12: DMEM medium at 
4°C for up to 3 days (72 h), in which good cell viability 
and population doubling time were maintained (Seet et al. 
2012). This has been possible due to the ability to culture-
expand skin cells in vitro and thus allow researchers to 
propagate and manipulate them for various purposes 
(Adha et al. 2008; Law et al. 2016; Manira et al. 2014; 
Mazlyzam et al. 2008, 2007, 2004; Muhd Fakhruddin et 
al. 2004; Norhayati et al. 2004; Ruszymah et al. 2011). 
There has been extensive initiatives for cryopreservation 
of different human-derived cells such as haematopoetic 
stem cells (Hunt et al. 2006; Liu et al. 2008; Rubinstein 
et al. 1995), mesenchymal stem cells (Woods et al. 2009; 
Zhou et al. 2004), embryonic stem cells (Zhou et al. 2004) 
and neural stem cells (Ortiz-Lopez et al. 2017). Several 
cryopreservation studies on epidermal cells involve the 
process of culturing and freezing (Pasch et al. 1999; Teepe 
et al. 1990). However, assessments of the condition of 
the cells following long-term cryopreservation has not 
been widely conducted (Roseeuw et al. 1991; Schiozer 
et al. 2013). Under certain circumstances, the collection 
of cells in advance and cryopreserving the cells is a good 
alternative, where the cells may be used at a later time 
for research purposes and possibly for further clinical 
applications. Currently, it is difficult to obtain human 
primary cells in the market as the cost is high.
 Cryopreservation will ensure continuous cell 
availability should contamination or problems during 
the culturing period or a shortage of cell supply occur. 
The best time to cryopreserve the cells is when they 
are at optimal growth or when the cells are reaching 
confluency. The risk of progressive loss of viability over 
time, associated with freezing and thawing procedures is 
minimised if the storage conditions are adequate (Rowley 
et al. 1994). The use of cryopreservation agents on stem 
cells has been shown to cause some adverse effects such 
as adverse transfusion reactions; and cellular damage 
during the process of cryopreservation (Brockbank et al. 
2011; Gurtovenko & Anwar 2007). Cells or samples that 
are cultured or manipulated have also been shown to have 
a higher rate of bacterial contamination as compared to 
fresh samples or product (Frey et al. 2006). Thus, this study 
was performed to assess the effect of cryopreservation on 
primary human dermal fibroblasts and keratinocytes and 
to evaluate the performance of these cells after 12 months 
of cryopreservation.
MATERIALS AND METHODS
PREPARATION AND CULTURE OF CELLS
Skin samples were obtained from surgery with consent 
from four healthy patients, aged between 6 and 60 years. 
The redundant skin (1 × 3 cm2) were cleaned thoroughly, 
swabbed using 70% alcohol and rinsed with Dulbecco’s 
phosphate buffered saline (DPBS) (Gibco/BRL, USA) before 
being cut into smaller pieces. The tissue samples were then 
digested in 0.6% Collagenase Type I for 5-6 h in a 37ºC 
shaker incubator. This was followed by digestion using 
0.05% Trypsin- EDTA for 8-10 min to dissociate the cells. 
The digested cell were then resuspended in co-culture 
medium [Epilife medium with Human keratinocytes 
growth supplement (HKGS) (Gibco/BRL, USA) + F12: DMEM 
(Sigma-Aldrich) with 10% FBS (Gibco/BRL, USA)] and 
cultured in three wells of a six-well plate at 37°C in 5% 
CO2 with replacement of medium every 2–3 days. After 
reaching 70-80% confluency, the fibroblasts were removed 
from the co-culture by using Tryple Select (Gibco/BRL, 
USA) and sub-cultured into T75 flask using FD+10% FBS 
until passage 3 (P3). The remaining keratinocytes were 
then cultured using Epilife medium in a six-well plate 
throughout the study. When the keratinocytes reached 70-
80% confluency, they were sub-cultured until a maximum 
of passage 3 (P3) with medium replaced every 2-3 days. 
MEASUREMENT OF CELL PROLIFERATION
The cell suspensions were diluted in Trypan Blue dye 
(Sigma, USA) and the viable and non-viable cells were 
determined by using a haemacytometer (Weber, UK). Total 
cell count and viability were performed for each passage 
before and after cryopreservation for one, three, six and 
twelve months. The growth rate for both keratinocytes 
and fibroblasts were calculated based on Chowdhury et 
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al. (2012) using the following equation (Chowdhury et 
al. 2012).
Growth rate (h-1) = Ln (Final/Initial cell   
  concentration)/time
CELL CRYOPRESERVATION
Keratinocytes and fibroblasts were trypsinised upon 
reaching 70-80% confluency. Determination of total 
cell number, viability and sterility were performed prior 
to cell cryopreservation. The appropriate cryo-medium 
(synth-a-freeze for keratinocytes and FBS +10% DMSO 
for fibroblasts) were added to the cell pellet to resuspend 
the cells. The concentration of the cell suspension in one 
cryotube was maintained at ~1 × 106 - 1.5 × 106 cells/mL. 
The cryotube was placed into CoolCell® freezing container 
(Corning, USA) and equilibrated at room temperature and 
then transferred into a -80°C freezer for 8-12 h. The frozen 
cells were later transferred into the vapour phase of the 
liquid nitrogen storage system for a maximum of one year 
for further analysis.
THAWING AND RE-CULTURE OF CRYOPRESERVED CELLS
The cryovials containing the cells were removed from 
the cryopreservation system (liquid nitrogen tank) and 
thawed at 37°C in a water bath with gentle shaking until 
it is thawed completely. The cells were then immediately 
transferred into a pre-warmed medium and seeded into 
six-well plates or T75 flasks.  The medium was replaced 
with a fresh medium to remove the cryoprotectant after 
the cells attached to the culture surface.
STERILITY TESTING
Sterility testing involved the use of cell suspensions before 
cryopreservation and spent medium after re-culture of the 
cryopreserved cells. The cell suspension or spent medium 
were transferred onto an agar plate via droplet or streaking. 
The agar plate was incubated at 37 ± 2ºC for at least 3 days 
before observation.
IMMUNOCYTOCHEMISTRY STAINING
Re-culture of fibroblasts and keratinocytes for 
cryopreservation at one, three, six and twelve months 
were fixed using 4% paraformaldehyde (Sigma- Aldrich) 
for 15 min. The samples were later permeabilised with 
0.1% Triton X-100 solution (Sigma-Aldrich) for 20 min 
and blocked with 10% goat serum (Sigma-Aldrich) for 1 
h at 37°C. The cells were later incubated using primary 
antibodies. Fibroblasts were conjugated using mouse anti-
Collagen type I monoclonal antibody (Abcam) whereas 
keratinocytes were conjugated using mouse anti-cytokeratin 
14 monoclonal antibody (Millipore), respectively. After 
24 h, cells were then incubated with Alexa Fluor 594 
goat anti-mouse IgG (Invitrogen) for 2 hours at 37°C 
and counterstained with 4’,6-diamidino-2-phenylindole 
(DAPI) (Dako) for 20 min. The immunocytochemistry 
staining results were analysed using a Nikon fluorescence 
microscope (Nikon, Tokyo).
STATISTICAL ANALYSIS
The quantitative results were analysed with one-way 
analysis of variance (ANOVA) and shown as the mean ± 
standard deviation (SD). The differences were considered 
as significant if the p-value is less than 0.05.
RESULTS AND DISCUSSION
Viability, Growth Profile Analysis and Cell Morphology
The viability of the cryopreserved cells gives an early 
indication whether cells were able to withstand the storage 
condition as well as the general overview of the effectiveness 
of the cryopreservation agents used in this particular study. 
The study showed that cell viability decreased with time 
for both keratinocytes and fibroblasts (65%± 3.5% - 89%± 
4.5%) (Figure 1), with significant differences between 
FIGURE 1. Percentage of viability of a) fibroblasts and b) keratinocytes. Both cells showed viability of more than 
60% after 12 months of cryopreservation. *represents significantly lower compared to 0 month. p < 0.05
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six months and twelve months as compared to the first 
month. The growth rate of the re-cultured keratinocytes and 
fibroblasts after being cryopreserved for 1-12 months were 
measured and the results showed no significant difference 
between all groups compared to the non-cryopreserved 
cells (0 month) (Figure 2). This indicates that the cells still 
proliferated actively even after being cryopreserved for 
twelve months.  However, there is slightly lower growth 
rate for the re-cultured fibroblasts at six months. In terms 
of cell morphology, keratinocytes appears to be cuboidal in 
shape (Figure 3) whilst fibroblasts appear to be elongated 
and spindle-shaped before and after cryopreservation 
(Figure 4). This indicates that both cells were able to 
maintain their morphologies even after twelve months of 
cryopreservation.
IMMUNOCYTOCHEMISTRY ANALYSIS
Immunocytochemistry analysis was performed to 
determine the expression of specific surface protein 
markers in the keratinocytes and fibroblasts. This helps 
to determine if there were variations in the expression 
of the protein markers before and after cryopreservation. 
Immunocytochemistry analysis showed positive expression 
of cytokeratin 14 (keratinocytes) (Figure 5) and collagen 
type I (fibroblasts) (Figure 6) even after twelve months of 
cryopreservation.  This indicates the ability of the cells 
to retain their characteristics in terms of specific protein 
expression after cryopreservation.                                                  
 Studies in the field of tissue engineering have brought 
a lot of promise in treating patients with various health 
conditions (Aminuddin & Ruszymah 2008; Ruszymah 
2008; Saim et al. 2004). The possibilities of regenerating 
living organs and tissues have helped researchers to 
embark on studies on different aspects of regenerative 
medicine. Therefore, in order to make this possible, the 
use of human-derived cells is of great importance as 
it will exert the best outcome on studies done in vitro. 
While many studies involved optimizing cell culture 
methods (Ibnubaidah et al. 2008; Yazid et al. 2008) 
FIGURE 2. Growth rate analysis of a) fibroblasts and b) keratinocytes. Both cells maintained their growth rate 
performance after 12 months of cryopreservation. *represents significantly lower compared to 0 month. p < 0.05
FIGURE 3. Phase contrast picture of keratinocytes. The cells morphology are cuboidal in shape 
and retain its morphology in a) control, and after b) 1 month, c) 3 months, d) 6 months, and e) 
12 months of cryopreservation. Scale bar is 100 μm
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FIGURE 4. Phase contrast picture of fibroblasts. The cells morphology are elongated and spindled-
shape and retain its morphology in a) control, and after a) 1 month, b) 3 months, c) 6 months, and 
d) 12 months of cryopreservation. Scale bar is 100 μm
and gene expression analysis (Ishak et al. 2011; Law et 
al. 2016), the evaluation of primary human cells after 
cryopreservation has been rarely reported. As the use of 
animal cells in research is beneficial (Alfaqeh et al. 2008), 
to bring better understanding and interpretation of human 
cell behaviour, and as the demand for cells in research and 
development increases, it is therefore necessary to develop 
cell and tissue banks and determine the optimum storage 
condition that is cost-effective (Naaldijk et al. 2016). Tissue 
engineering is an emerging field of science, and a number 
of research institutes, even biotechnology companies are 
now venturing into catering research and development 
in the field of regenerative medicine. Hence, a number 
of companies, mostly based in USA, are now undertaking 
commercialisation of different types of ready-to-use cells. 
Unfortunately, the prices of these cells are very high, due 
to the cost of export, customs clearance, and taxes. Thus, it 
seems appropriate to develop an in-house cell distribution 
facility that is reachable to the local research institutes 
in Malaysia. Developing an efficient cryopreservation 
protocol and its validation is the first step towards it.
 Studies have shown that cells can be successfully 
cryopreserved by using DMSO as a cryoprotecting agent 
(Stolzing et al. 2012). Studies have been carried out to 
investigate the use of different concentrations of DMSO 
for cell freezing (Stolzing et al. 2012); and also of DMSO 
combinations with different cryoprotectants (Naaldijk 
et al. 2016). We have used the combination of feotal 
bovine serum with 10% DMSO as the cryopreservation 
agent in this particular study. The decrease in viability is 
expected. According to Hunt et al. (2003), even though 
the cooling rates of 1-2.5ºC/min are probably optimal 
for DMSO concentrations of 5-10%, recovery of the cells 
post-cryopreservation can be improved if the osmotic 
damage that occurs through the introduction and removal 
of the cryoprotectant is tempered by the application of 
slow addition or elution protocols (Hunt et al. 2003). 
Nonetheless, Naaldijk et. al (2016) has also shown that 
the combination of DMSO and hydroxyethyl compound 
at a certain ratio might give a better cell yield post-
cryopreservation. This is interesting for the researchers to 
look into as the use of other reagents may affect the cell 
viability and performance during cryopreservation. During 
cell cryopreservation, cells experience sudden changes in 
temperature in a short period of time which may cause cold 
shock, osmotic injury and intracellular ice formation (Gao 
& Critser 2000). Even though the cell viability decreased 
after twelve months of cryopreservation, both keratinocytes 
and fibroblasts still show an acceptable viability of more 
than 60% (Figure 1). This is supported by Yanaga et al. 
(2017) which reported that the viability for cryopreserved 
cultured epithelial cells was approximately  60% after a 
year of cryopreservation (Yanaga et al. 2017). Another 
important issue to be considered is the technique and 
methods of freezing (Schiozer et al. 2013). Cells should 
be cooled gradually and thawed rapidly in order to achieve 
a good viable number of cells (Udoh et al. 2000), similar 
to what is done in the present study. 
 As the cells are being culture-expanded and 
cryopreserved, the evaluation of protein expression is 
important to detect any changes in its specific proteins. 
Immunocytochemistry analysis was performed to evaluate 
the expression of CK-14 in keratinocytes and collagen type-I 
in fibroblasts. After twelve months of cryopreservation, 
both markers were expressed by both cells, respectively. 
CK-14 is a basal-type cytokeratin and expressed in basal 
cells of multi-layered epithelia (Bocker 2002). Katayama et 
al. (2015) previously conducted a study on the differences 
in gene expression in keratinocytes from different 
sources. The results showed that cultured keratinocytes 
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expressed a significant amount of CK-14 even after serial 
passaging which indicates cells were able to maintain their 
proliferative activity after serial passaging (Katayama et al. 
2015). In addition, a study by Alam et al. (2011) indicates 
that CK-14 played an important role as a negative regulator 
of cell differentiation and may act as a possible control in 
terms of the squamous differentiation process (Alam et 
al. 2011). In contrast, collagen type I is known to be an 
integral structural component of the extracellular matrix in 
the dermal layer of skin mainly synthesised by fibroblasts 
(Chen et al. 1999). A study by Kim et al. (2014) showed 
that type I collagen in human skin acted as the main factor 
in skin aging and skin remodelling (Kim et al. 2014). Thus, 
the expression of the specific protein CK-14 and collagen 
type I after long-term cryopreservation showed that the 
keratinocytes and fibroblasts were able to maintain their 
important phenotype (Figures 5 & 6). 
CONCLUSION
We have successfully assessed the characteristics of 
primary human skin cells after cryopreservation and 
FIGURE 6. Immunocytochemical analysis of fibroblasts.  The specific markers for fibroblast (Collagen type I) 
were strongly expressed (marked with green colour) for a) control, and after b) 1 month, c) 3 months, 
d) 6 months, and e) 12 months of cryopreservation. Scale bar is 100 μm
FIGURE 5. Immunocytochemical analysis of keratinocytes. The specific markers for keratinocytes 
(Cytokeratin 14) were strongly expressed (marked with green colour) for a) control, and  
after b) 1 month, c) 3 months,  d) 6 months, and e) 12 months of cryopreservation. Scale bar is 100 μm
  143
showed that the cells are able to maintain expression of 
specific proteins. Even though the cell number and viability 
decreased with time, the cells remained within the range 
above 60% in terms of viability and a cell count of more 
than 500,000 cells/vial. However, further investigation 
using longer periods of cryopreservation (e.g 24 months, 
48 months) should be conducted. The authors declare that 
they have no conflict of interest.
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